|
1
|
Tomlinson JS, Jarnagin WR, DeMatteo RP,
Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH and
D'Angelica M: Actual 10-year survival after resection of colorectal
liver metastases defines cure. J Clin Oncol. 25:4575–4580. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parks R, Gonen M, Kemeny N, Jarnagin W,
D'Angelica M, DeMatteo R, Garden OJ, Blumgart LH and Fong Y:
Adjuvant chemotherapy improves survival after resection of hepatic
colorectal metastases: Analysis of data from two continents. J Am
Coll Surg. 204:753–763. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nordlinger B, Sorbye H, Glimelius B,
Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole
ET and Finch-Jones M: Perioperative chemotherapy with FOLFOX4 and
surgery versus surgery alone for resectable liver metastases from
colorectal cancer (EORTC Intergroup trial 40983): A randomised
controlled trial. Lancet. 371:1007–1016. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khatri VP, Petrelli NJ and Belghiti J:
Extending the frontiers of surgical therapy for hepatic colorectal
metastases: Is there a limit? J Clin Oncol. 23:8490–8499. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leonard GD, Brenner B and Kemeny NE:
Neoadjuvant chemotherapy before liver resection for patients with
unresectable liver metastases from colorectal carcinoma. J Clin
Oncol. 23:2038–2048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rubbia-Brandt L, Audard V, Sartoretti P,
Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane
O and Chaussade S: Severe hepatic sinusoidal obstruction associated
with oxaliplatin-based chemotherapy in patients with metastatic
colorectal cancer. Ann Oncol. 15:460–466. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakano H, Oussoultzoglou E, Rosso E,
Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P and Jaeck D:
Sinusoidal injury increases morbidity after major hepatectomy in
patients with colorectal liver metastases receiving preoperative
chemotherapy. Ann Surg. 247:118–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolf PS, Park JO, Bao F, Allen PJ,
DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M and Kemeny N:
Preoperative chemotherapy and the risk of hepatotoxicity and
morbidity after liver resection for metastatic colorectal cancer: A
single institution experience. J Am Coll Surg. 216:41–49. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vauthey JN, Pawlik TM, Ribero D, Wu TT,
Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY and Mino-Kenudson M:
Chemotherapy regimen predicts steatohepatitis and an increase in
90-day mortality after surgery for hepatic colorectal metastases. J
Clin Oncol. 24:2065–2072. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karoui M, Penna C, Amin-Hashem M, Mitry E,
Benoist S, Franc B, Rougier P and Nordlinger B: Influence of
preoperative chemotherapy on the risk of major hepatectomy for
colorectal liver metastases. Ann Surg. 243:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kooby DA, Fong Y, Suriawinata A, Gonen M,
Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH and
Jarnagin WR: Impact of steatosis on perioperative outcome following
hepatic resection. J Gastrointest Surg. 7:1034–1044. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Renfro LA, Loupakis F, Adams RA, Seymour
MT, Heinemann V, Schmoll HJ, Douillard JY, Hurwitz H, Fuchs CS and
Diaz-Rubio E: Body mass index is prognostic in metastatic
colorectal cancer: Pooled analysis of patients from first-line
clinical trials in the ARCAD database. J Clin Oncol. 34:144–150.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balzan S, Nagarajan G, Farges O, Galleano
CZ, Dokmak S, Paugam C and Belghiti J: Safety of liver resections
in obese and overweight patients. World J Surg. 34:2960–2968. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Viganò L, Kluger MD, Laurent A, Tayar C,
Merle JC, Lauzet JY, Andreoletti M and Cherqui D: Liver resection
in obese patients: Results of a case-control study. HPB (Oxford).
13:103–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pi-Sunyer FX: Medical hazards of obesity.
Ann Intern Med. 119:655–660. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Veteläinen R, van Vliet A, Gouma DJ and
van Gulik TM: Steatosis as a risk factor in liver surgery. Ann
Surg. 245:20–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
André T, Louvet C, Maindrault-Goebel F,
Couteau C, Mabro M, Lotz JP, Gilles-Amar V, Krulik M, Carola E,
Izrael V and de Gramont A: CPT-11 (irinotecan) addition to
bimonthly, high-dose leucovorin and bolus and continuous-infusion
5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal
cancer. GERCOR. Eur J Cancer. 35:1343–1347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
André T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P
and Bridgewater J: Oxaliplatin, fluorouracil, and leucovorin as
adjuvant treatment for colon cancer. N Engl J Med. 350:2343–2351.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pang YY: The Brisbane 2000 terminology of
liver anatomy and resections. HPB 2000. 2:333–339, HPB (Oxford) 4:
99–100. 2002.
|
|
20
|
Kleiner DE, Brunt EM, Van Natta M, Behling
C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS and
Unalp-Arida A: Design and validation of a histological scoring
system for nonalcoholic fatty liver disease. Hepatology.
41:1313–1321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
World Health Organization Europe: Obesity.
Data and Statistic - 2015. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/obesity/data-and-statisticsAccessed.
August 28–2016.
|
|
22
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Capussotti L, Ferrero A, Viganò L, Sgotto
E, Muratore A and Polastri R: Bile leakage and liver resection:
Where is the risk? Arch Surg. 141:690–695. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balzan S, Belghiti J, Farges O, Ogata S,
Sauvanet A, Delefosse D and Durand F: The ‘50-50 criteria’ on
postoperative day 5: An accurate predictor of liver failure and
death after hepatectomy. Ann Surg. 242:824–829. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bellomo R, Ronco C, Kellum JA, Mehta RL
and Palevsky P: Acute Dialysis Quality Initiative workgroup: Acute
renal failure-definition, outcome measures, animal models, fluid
therapy and information technology needs: The second international
consensus conference of the acute dialysis quality initiative
(ADQI) Group. Crit Care. 8:R204–R212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reissfelder C, Brand K, Sobiegalla J,
Rahbari NN, Bork U, Schirmacher P, Büchler MW, Weitz J and Koch M:
Chemotherapy-associated liver injury and its influence on outcome
after resection of colorectal liver metastases. Surgery.
155:245–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Behrns KE, Tsiotos GG, DeSouza NF, Krishna
MK, Ludwig J and Nagorney DM: Hepatic steatosis as a potential risk
factor for major hepatic resection. J Gastrointest Surg. 2:292–298.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaffner F and Thaler H: Nonalcoholic
fatty liver disease. Prog Liver Dis. 8:283–298. 1986.PubMed/NCBI
|
|
29
|
Brouquet A, Benoist S, Julie C, Penna C,
Beauchet A, Rougier P and Nordlinger B: Risk factors for
chemotherapy-associated liver injuries: A multivariate analysis of
a group of 146 patients with colorectal metastases. Surgery.
145:362–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fernandez FG, Ritter J, Goodwin JW,
Linehan DC, Hawkins WG and Strasberg SM: Effect of steatohepatitis
associated with irinotecan or oxaliplatin pretreatment on
resectability of hepatic colorectal metastases. J Am Coll Surg.
200:845–853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pawlik TM, Olino K, Gleisner AL, Torbenson
M, Schulick R and Choti MA: Preoperative chemotherapy for
colorectal liver metastases: Impact on hepatic histology and
postoperative outcome. J Gastrointest Surg. 11:860–868. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mathur AK, Ghaferi AA, Sell K, Sonnenday
CJ, Englesbe MJ and Welling TH: Influence of body mass index on
complications and oncologic outcomes following hepatectomy for
malignancy. J Gastrointest Surg. 14:849–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Langella S, Russolillo N, Forchino F, Lo
Tesoriere R, D'Eletto M and Ferrero A: Impact of obesity on
postoperative outcome of hepatic resection for colorectal
metastases. Surgery. 158:1521–1529. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bower M, Wunderlich C, Brown R, Scoggins
CR, McMasters KM and Martin RC: Obesity rather than neoadjuvant
chemotherapy predicts steatohepatitis in patients with colorectal
metastasis. Am J Surg. 205:685–690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Day CP and James OF: Steatohepatitis: A
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gascón P, Zoumbos NC and Young NS:
Immunologic abnormalities in patients receiving multiple blood
transfusions. Ann Intern Med. 100:173–177. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tadros T, Wobbes T and Hendriks T: Blood
transfusion impairs the healing of experimental intestinal
anastomoses. Ann Surg. 215:276–281. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fujimoto J, Okamoto E, Yamanaka N, Tanaka
T and Tanaka W: Adverse effect of perioperative blood transfusions
on survival after hepatic resection for hepatocellular carcinoma.
Hepatogastroenterology. 44:1390–1396. 1997.PubMed/NCBI
|
|
39
|
Kooby DA, Stockman J, Ben-Porat L, Gonen
M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH and
Fong Y: Influence of transfusions on perioperative and long-term
outcome in patients following hepatic resection for colorectal
metastases. Ann Surg. 237:860–870. 2003. View Article : Google Scholar : PubMed/NCBI
|
